Epstein-Barr Virus by Quantitative NAAT, Plasma

Also known as: EBVQ

Clinical Use

Use

The Epstein-Barr Virus by Quantitative NAAT, Plasma test is used to detect and quantify the presence of Epstein-Barr virus (EBV) in plasma samples. This test is commonly used for monitoring viral load in patients who may be at risk for complications from EBV infection, such as transplant recipients. Quantifying EBV can help guide clinical decisions regarding diagnosis and treatment strategies. The assay offers improved comparability across laboratories due to international standardization but may still present some variability due to commutability issues with the standard.

Special Instructions

Not provided.

Limitations

The test has a quantitative range of 1.54-8.00 log IU/mL (35.0-100,000,000 IU/mL). An interpretation of "Not Detected" does not entirely rule out the presence of EBV due to potential inhibitors or concentrations below the assay's sensitivity level. While standardized to improve consistency across laboratories, the results might vary due to specific commutability issues inherent to the standard used across different laboratories.

Test Details

New York Approved

Methodology

PCR-based (qPCR)

Biomarkers

LOINC Codes

Order Codes

100677-4 - EBV DNA SerPl NAA+probe-Log#
43730-1 - EBV DNA SerPl NAA+probe-aCnc
5005-4 - EBV DNA Spec Ql NAA+probe

Result Codes

43730-1 - EBV DNA SerPl NAA+probe-aCnc
100677-4 - EBV DNA SerPl NAA+probe-Log#
5005-4 - EBV DNA Spec Ql NAA+probe

Result Turnaround Time

1-4 days

Specimen

Plasma

Volume

2 mL

Minimum Volume

1 mL

Container

ARUP standard transport tube

Collection Instructions

Separate from cells within 24 hours of collection. Transfer to an ARUP standard transport tube using ARUP Connect or contact ARUP Client Services for supplies.